Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


2nd Reverse Phase Protein Array Global Workshop

12 Nov 2012 - 13 Nov 2012 - Edinburgh, Scotland, UK



Bookmark and Share


Key Workstreams;

  • Challenges, needs, advantages and disadvantages associated with printing and detection
  • Image acquisition, data processing and normalization
  • Validating and sharing of Antibody data
  • Alignment with "Proteomics Standard Initiative" (PSI) at HUPO
  • New technologies showcase
  • Pharmaceutical Discovery applications
  • RPPA in management and analysis of clinical samples
  • How to use RPA Data in the Clinic (i.e. PD Marker, Prognostic Marker and Predictive Marker):
  • Launch : Global RPPA Society


The evolution of Reverse Phase Protein Array (RPPA ) technologies has facilitated the application of high-throughput functional proteomics in patient samples and preclinical drug screening with improved sensitivity and quantification to support the identification and analysis of post-translational biomarkers and pathway networks.

Advancing RPPA technology into mainstream basic research, drug discovery and clinical diagnostics applications will require improved consistency in methods and an expanded portfolio of validated antibody reagents and procedures that can be shared across the community.

Hosted by the University of Edinburgh, the second Reverse Phase Protein Array Global Workshop will bring together scientists from both academia and industry to discuss the latest technical advances and standards for generating and analysing results using Reverse Phase Protein Arrays.

The 2012 workshop shall also be used to launch a global RPPA society to support communication, data-sharing and ambitions of the RPPA community.



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!